{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:47:26Z","timestamp":1791863246426,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,2]],"date-time":"2027-09-02T00:00:00Z","timestamp":1819843200000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI101047"],"award-info":[{"award-number":["R01AI101047"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI143844"],"award-info":[{"award-number":["R01AI143844"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nano.2026.103008","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:58:37Z","timestamp":1787122717000},"page":"103008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Saponin derivative and MPLA-adjuvanted intranasal protein nanoparticle vaccines induce potent mucosal immunity and durable heterologous influenza protection in mice"],"prefix":"10.1016","volume":"77","author":[{"given":"Lai","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arini","family":"Arsana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Omotara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.103008_bb0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s12276-021-00603-0","article-title":"The evolution and future of influenza pandemic preparedness","volume":"53","author":"Harrington","year":"2021","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.nano.2026.103008_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0015","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103008_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0030","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41587-024-02486-8","article-title":"Challenges for developing broad-based mucosal vaccines for respiratory viruses","volume":"42","author":"Seo","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2026.103008_bb0035","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/517952","article-title":"Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient","volume":"28","author":"Kamboj","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.nano.2026.103008_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"479-480","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.nano.2026.103008_bb0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2026.103008_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010068","article-title":"Promising adjuvants and platforms for influenza vaccine development","volume":"13","author":"Zhu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.103008_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2026.103008_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2026.103008_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1060028018758431","article-title":"Shingrix: the new adjuvanted recombinant herpes zoster vaccine","volume":"52","author":"James","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nano.2026.103008_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf1152","article-title":"A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity","volume":"6","author":"Silva","year":"2021","journal-title":"Sci Immunol."},{"key":"10.1016\/j.nano.2026.103008_bb0075","doi-asserted-by":"crossref","first-page":"eadn7187","DOI":"10.1126\/sciadv.adn7187","article-title":"Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses","volume":"10","author":"Ou","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2026.103008_bb0080","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185292","article-title":"The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates","volume":"135","author":"Ramezani-Rad","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2026.103008_bb0085","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00044-024-03227-x","article-title":"Development of semisynthetic saponin immunostimulants","volume":"33","author":"Bai","year":"2024","journal-title":"Med Chem Res"},{"key":"10.1016\/j.nano.2026.103008_bb0090","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1021\/acs.jmedchem.9b01511","article-title":"Vaccine adjuvants derivatized from Momordica saponins I and II","volume":"62","author":"Wang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2026.103008_bb0095","doi-asserted-by":"crossref","first-page":"14589","DOI":"10.1021\/acs.jmedchem.2c01087","article-title":"Structure-activity relationship study of Momordica saponin II derivatives as vaccine adjuvants","volume":"65","author":"Kim","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2026.103008_bb0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14760584.2024.2382725","article-title":"Adjuvant system AS01: from mode of action to effective vaccines","volume":"23","author":"Roman","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2026.103008_bb0105","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0110","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1021\/acs.jmedchem.9b02063","article-title":"Structural effect on adjuvanticity of saponins","volume":"63","author":"Wang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2026.103008_bb0115","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/nprot.2014.180","article-title":"Influenza A virus isolation, culture and identification","volume":"9","author":"Eisfeld","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nano.2026.103008_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202301801","article-title":"ISCOMs\/MPLA-adjuvanted SDAD protein nanoparticles induce improved mucosal immune responses and cross-protection in mice","volume":"19","author":"Zhu","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.nano.2026.103008_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.omtn.2022.10.024","article-title":"cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice","volume":"30","author":"Zhu","year":"2022","journal-title":"Mol Ther Nucl Acids"},{"key":"10.1016\/j.nano.2026.103008_bb0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","article-title":"Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses","volume":"9","author":"Deng","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103008_bb0135","article-title":"Influenza NP core and HA or M2e shell double-layered protein nanoparticles induce broad protection against divergent influenza A viruses","volume":"40","author":"Ma","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2026.103008_bb0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/eji.1830260323","article-title":"Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells","volume":"26","author":"Heufler","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.nano.2026.103008_bb0150","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2014.03.078","article-title":"How advances in immunology provide insight into improving vaccine efficacy","volume":"32","author":"Slifka","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2026.103008_bb0155","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","article-title":"Principles and therapeutic applications of adaptive immunity","volume":"187","author":"Chi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.nano.2026.103008_bb0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nri3322","article-title":"New concepts in the generation and functions of IgA","volume":"12","author":"Pabst","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41385-021-00461-z","article-title":"Tissue resident memory T cells in the respiratory tract","volume":"15","author":"Zheng","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0170","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3389\/fimmu.2018.01574","article-title":"A systematic review: the role of resident memory T cells in infectious diseases and their relevance for vaccine development","volume":"9","author":"Muruganandah","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-0716-1001-5_15","article-title":"Cellular and biochemical analysis of bronchoalveolar lavage fluid from murine lungs","volume":"2223","author":"Kalidhindi","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nano.2026.103008_bb0180","article-title":"Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration","volume":"123","author":"Van Hoecke","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.nano.2026.103008_bb0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41577-022-00815-z","article-title":"Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases","volume":"23","author":"Carbone","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41541-023-00665-3","article-title":"Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection","volume":"8","author":"Diallo","year":"2023","journal-title":"NPJ Vacc"},{"key":"10.1016\/j.nano.2026.103008_bb0195","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice","volume":"8","author":"He","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103008_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003207","article-title":"Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity","volume":"9","author":"Laidlaw","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2026.103008_bb0205","doi-asserted-by":"crossref","first-page":"E7758","DOI":"10.1073\/pnas.1805713115","article-title":"Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice","volume":"115","author":"Deng","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2026.103008_bb0210","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.4049\/jimmunol.1100987","article-title":"Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells","volume":"187","author":"Ho","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2007.10.010","article-title":"Antigen presentation by monocytes and monocyte-derived cells","volume":"20","author":"Randolph","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111828","article-title":"Alveolar macrophages instruct CD8(+) T cell expansion by antigen cross-presentation in lung","volume":"41","author":"Kawasaki","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.nano.2026.103008_bb0225","doi-asserted-by":"crossref","first-page":"L936","DOI":"10.1152\/ajplung.90625.2008","article-title":"Lung environment determines unique phenotype of alveolar macrophages","volume":"296","author":"Guth","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.nano.2026.103008_bb0230","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0235","doi-asserted-by":"crossref","first-page":"913","DOI":"10.15585\/mmwr.mm7129a1","article-title":"Influenza activity and composition of the 2022\u201323 influenza vaccine - United States, 2021\u201322 season","volume":"71","author":"Merced-Morales","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.nano.2026.103008_bb0240","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2471\/BLT.21.287253","article-title":"United States Centers for Disease Control and Prevention support for influenza surveillance, 2013\u20132021","volume":"100","author":"McCarron","year":"2022","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.nano.2026.103008_bb0245","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1038\/s41467-024-50087-5","article-title":"Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines","volume":"15","author":"Dong","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.103008_bb0250","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1039\/D4NH00287C","article-title":"Double-layered protein nanoparticles conjugated with truncated flagellin induce improved mucosal and systemic immune responses in mice","volume":"9","author":"Kim","year":"2024","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.nano.2026.103008_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128255","article-title":"VSA-2-, a novel plant-derived adjuvant for SARS-CoV-2 subunit vaccine","volume":"75","author":"Adam","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2026.103008_bb0260","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nchem.1963","article-title":"Development of a minimal saponin vaccine adjuvant based on QS-21","volume":"6","author":"Fernandez-Tejada","year":"2014","journal-title":"Nat Chem"},{"key":"10.1016\/j.nano.2026.103008_bb0265","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1128\/JVI.72.6.4931-4939.1998","article-title":"Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes","volume":"72","author":"Sasaki","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2026.103008_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2013.11.013","article-title":"Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine","volume":"174","author":"Patil","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.103008_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136862","article-title":"A novel prime and boost regimen of HIV virus-like particles with TLR4 adjuvant MPLA induces Th1 oriented immune responses against HIV","volume":"10","author":"Poteet","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.nano.2026.103008_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645210","article-title":"Vaccine inoculation route modulates early immunity and consequently antigen-specific immune response","volume":"12","author":"Rosenbaum","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105941","article-title":"Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles - a recombinant vaccine candidate","volume":"228","author":"Zimna","year":"2024","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2026.103008_bb0290","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1084\/jem.20181365","article-title":"CD4(+) resident memory T cells dominate immunosurveillance and orchestrate local recall responses","volume":"216","author":"Beura","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2026.103008_bb0295","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.nano.2026.103008_bb0300","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri3166","article-title":"Regulating the adaptive immune response to respiratory virus infection","volume":"12","author":"Braciale","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2026.103008_bb0305","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","article-title":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology","volume":"38","author":"Newton","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.nano.2026.103008_bb0310","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.8.2300239","article-title":"Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010\/11 to 2018\/19","volume":"29","author":"Chung","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.nano.2026.103008_bb0315","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.vaccine.2022.02.088","article-title":"Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: a global, multiseasonal, controlled, randomized phase III study","volume":"40","author":"Esposito","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2026.103008_bb0320","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1093\/cid\/ciaa340","article-title":"Waning of measured influenza vaccine effectiveness over time: the potential contribution of leaky vaccine effect","volume":"71","author":"Tokars","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:23:58Z","timestamp":1791861838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S1549963426001097"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.103008","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saponin derivative and MPLA-adjuvanted intranasal protein nanoparticle vaccines induce potent mucosal immunity and durable heterologous influenza protection in mice","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.103008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103008"}}